Genetix Group plc Awarded Scottish NHS Cytogenetics Contract
News Sep 03, 2008
Genetix Group the cancer diagnostic and biopharmaceutical technologies group, today announces that it has been awarded a contract to develop and implement a nationwide network of Automated Cytogenetic Analysis Systems by NHS National Services Scotland (“NHS Scotland”).
Cytogenetics is the investigation of the structure, function, and abnormalities of human chromosomes, and Genetix’s CytoVision® is the most widely used imaging and analysis cytogenetics workstation in the world. The project will connect NHS Scotland’s five cytogenetic laboratories - located in Aberdeen, Dundee, Edinburgh, Glasgow and Inverness - through a network of over 70 CytoVision workstations, delivering a completely integrated, standardised, automated cytogenetic analysis solution. The network, which is replacing
current microscope-based chromosome analysis methods, will enable the laboratories to balance workloads by sharing digital images across all 5 locations through CytoVision’s Web Service capabilities and the NHS Scotland Wide Area Network.
Commenting on today’s announcement, Eddy Maher, Director of Cytogenetic Services, NHS Lothian, said:
“The CytoVision network enables us to implement a number of significant improvements which the NHS has targeted as priorities - with the primary goal to provide a uniformly high level of service to every patient in Scotland. This automated solution facilitates connectivity and standardisation across all of Scotland’s cytogenetic laboratories. It enables us to balance workloads, reduce reporting times and improve quality.”
Simon Smith, Genetix’s Director of Commercial Operations, Europe, said:
“We are delighted that Genetix’s CytoVision systems have been selected for a project of such national importance. We have worked diligently to develop a scientific, technological, information management solution to connect Scotland’s entire network of cytogenetic laboratories. By integrating our CytoVision imaging and analysis system with our new GSL-
120 Slide Loader, and employing the newly-released CytoVision V.4 software platform, the network will provide a workflow solution that significantly reduces cost, saves time and delivers excellence in the quality of analysis.”
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE